GAMMA Investing LLC Acquires 126,190 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

GAMMA Investing LLC lifted its stake in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 22,374.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 126,754 shares of the semiconductor company's stock after purchasing an additional 126,190 shares during the period. GAMMA Investing LLC owned 0.39% of Silicon Laboratories worth $14,269,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Jones Financial Companies Lllp lifted its position in shares of Silicon Laboratories by 44.5% in the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 69 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Silicon Laboratories in the 4th quarter worth about $70,000. Venturi Wealth Management LLC lifted its position in shares of Silicon Laboratories by 207.0% in the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock worth $98,000 after purchasing an additional 530 shares during the period. Asset Management One Co. Ltd. purchased a new stake in shares of Silicon Laboratories in the 4th quarter worth about $117,000. Finally, O Shaughnessy Asset Management LLC purchased a new stake in shares of Silicon Laboratories in the 4th quarter worth about $214,000.

Wall Street Analyst Weigh In

SLAB has been the subject of several research analyst reports. Wall Street Zen raised shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 14th. Barclays decreased their price target on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 22nd. Susquehanna increased their price target on shares of Silicon Laboratories from $100.00 to $110.00 and gave the stock a "neutral" rating in a research note on Wednesday, May 14th. Needham & Company LLC reiterated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Finally, Benchmark reiterated a "buy" rating and issued a $160.00 price target on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Silicon Laboratories presently has an average rating of "Moderate Buy" and a consensus target price of $126.50.

Silicon Laboratories Trading Up 2.1%

NASDAQ:SLAB traded up $2.65 on Friday, reaching $126.60. 308,306 shares of the stock traded hands, compared to its average volume of 338,380. The company has a market capitalization of $4.12 billion, a price-to-earnings ratio of -21.31 and a beta of 1.36. Silicon Laboratories Inc. has a 12 month low of $82.82 and a 12 month high of $160.00. The company's fifty day simple moving average is $109.53 and its 200 day simple moving average is $122.86.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. The business had revenue of $177.71 million during the quarter, compared to analyst estimates of $177.48 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. Silicon Laboratories's revenue was up 67.0% compared to the same quarter last year. During the same period last year, the business earned ($0.92) EPS. Equities analysts anticipate that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.

Insider Activity

In other Silicon Laboratories news, CEO Robert Matthew Johnson sold 5,879 shares of Silicon Laboratories stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $131.20, for a total transaction of $771,324.80. Following the transaction, the chief executive officer now owns 73,688 shares of the company's stock, valued at $9,667,865.60. The trade was a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Christy Wyatt sold 546 shares of Silicon Laboratories stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total transaction of $57,029.70. Following the transaction, the director now directly owns 8,492 shares in the company, valued at $886,989.40. This represents a 6.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,626 shares of company stock valued at $1,509,319 in the last 90 days. 1.60% of the stock is currently owned by insiders.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.